Bank of America’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41K | Buy |
|
|||||
|
2025
Q1 | $213 | Sell |
|
|||||
|
2024
Q4 | $1.23K | Buy |
|
|||||
|
2024
Q3 | $244 | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $718 | Sell |
|
|||||
|
2023
Q3 | $1.32K | Hold |
|
|||||
|
2023
Q2 | $2.2K | Hold |
|
|||||
|
2023
Q1 | $3.05K | Buy |
|
|||||
|
2022
Q4 | $2.55K | Sell |
|
|||||
|
2022
Q3 | $3K | Sell |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $34K | Buy |
|
|||||
|
2021
Q4 | $21K | Sell |
|
|||||
|
2021
Q3 | $36K | Buy |
|
|||||
|
2021
Q2 | $8K | Sell |
|
|||||
|
2021
Q1 | $35K | Buy |
|
|||||
|
2020
Q4 | $26K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $0 | Buy |
|